A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort

Per prescribing guidance, remdesivir is not recommended for SARS-CoV-2 in patients with renal disease given the absence of safety data in this patient population. This study was a multicenter, retrospective chart review of hospitalized patients with SARS-CoV-2 who received remdesivir. Safety outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackley, Tyler W., McManus, Dayna, Topal, Jeffrey E., Cicali, Brian, Shah, Sunish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849020/
https://www.ncbi.nlm.nih.gov/pubmed/33229428
http://dx.doi.org/10.1128/AAC.02290-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849020/
https://www.ncbi.nlm.nih.gov/pubmed/33229428
http://dx.doi.org/10.1128/AAC.02290-20

Ejemplares similares